about
Stem Cells Applications in Regenerative Medicine and Disease Therapeutics.A Perspective of Immunotherapy for Breast Cancer: Lessons Learned and Forward Directions for All CancersAdoptive T-cell therapy for cancer: The era of engineered T cellsT cell engineering as therapy for cancer and HIV: our synthetic futureImproving the safety of cell therapy with the TK-suicide geneLoss of Angiopoietin-like 7 diminishes the regeneration capacity of hematopoietic stem and progenitor cells.Thymic expression of a T-cell receptor targeting a tumor-associated antigen coexpressed in the thymus induces T-ALLNoninvasive detection of tumor-infiltrating T cells by PET reporter imaging.In Vivo Tracking of Human Hematopoiesis Reveals Patterns of Clonal Dynamics during Early and Steady-State Reconstitution PhasesA role for multiple chimeric antigen receptor-expressing leukocytes in antigen-specific responses to cancer.In vivo transduction of primitive mobilized hematopoietic stem cells after intravenous injection of integrating adenovirus vectorsEngineering T cells for cancer: our synthetic future.Propagating Humanized BLT Mice for the Study of Human Immunology and Immunotherapy.Translational Implications for Off-the-shelf Immune Cells Expressing Chimeric Antigen Receptors.Current treatment options of T cell-associated immunotherapy in multiple myeloma.Direct bone marrow HSC transplantation enhances local engraftment at the expense of systemic engraftment in NSG mice.Pre-clinical development of gene modification of haematopoietic stem cells with chimeric antigen receptors for cancer immunotherapy.T-cell immunotherapy: looking forward.Stem cells in cancer therapy: opportunities and challenges.Long-term persistence and function of hematopoietic stem cell-derived chimeric antigen receptor T cells in a nonhuman primate model of HIV/AIDS.New Approaches in CAR-T Cell Immunotherapy for Breast Cancer.The Use of the Humanized Mouse Model in Gene Therapy and Immunotherapy for HIV and Cancer.
P2860
Q26741792-84029FD0-16A1-4FBF-9F62-20C5D1CE0D5DQ26777111-507BFCFB-3B01-4506-8BCF-764DAB1C697AQ26800611-3CAF15D3-AB3F-4CCE-A7D9-7C6DF5DAFD2AQ28082253-577F7E2D-1199-4137-AFA7-5C7C08CBC59AQ34477411-AB12B625-3188-4853-93BA-7C9024E80DB2Q35158611-CBBE79BA-A709-4EC3-939F-8DB5DCE331B0Q35583414-A1C97435-2A92-441D-B37B-AB51E84F7313Q35719906-5BF44091-0DA9-4CEC-9E09-57801CCF86C1Q37089345-4E131034-491C-4A9B-A3CD-5BB235E08873Q37376346-C7967D4F-B03D-4871-8DEC-B54FA3FE9F23Q37394036-94EDB652-0D12-4249-B26F-3E1748D5F406Q37515502-B30F9FAF-7CBF-4B66-B489-5FBC5FE6761AQ38409791-9AACB610-C00D-424F-A55B-2D4736CC06A2Q38839878-BA5F4F58-0C76-4327-B55C-5EC410FFEF3EQ39102170-74A6EB10-A032-4345-8C86-3BE6F13190D9Q40025549-04121EB9-0765-4B23-8886-F6A08F9B1F7FQ40393182-2C669A14-B092-4242-96E3-2A9D19748FAEQ42549120-177BE6D3-67EC-4E6F-8E79-F82C556D0FFAQ47142453-3667DBDD-9EBC-4FCB-AFA3-2D0F7972DBCAQ47172279-868C60EA-02DF-4B65-98D2-DA91E5403B89Q47761448-FE74478A-5145-4B85-AEFB-F1CE48E0261CQ55078034-BBE46EDA-D6DD-45C5-A322-4186B97D6911
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Hematopoietic stem cells for cancer immunotherapy
@en
Hematopoietic stem cells for cancer immunotherapy.
@nl
type
label
Hematopoietic stem cells for cancer immunotherapy
@en
Hematopoietic stem cells for cancer immunotherapy.
@nl
prefLabel
Hematopoietic stem cells for cancer immunotherapy
@en
Hematopoietic stem cells for cancer immunotherapy.
@nl
P2860
P356
P1476
Hematopoietic stem cells for cancer immunotherapy
@en
P2093
Eric Gschweng
P2860
P304
P356
10.1111/IMR.12128
P577
2014-01-01T00:00:00Z